Renal and vascular effects of chronic endothelin receptor antagonism in malignant hypertensive rats

American Journal of Hypertension

Volumn 9, Issue 8 I, 1996, Pages 803-811

  Li, Jin S ^a   Schürch, Walter ^b   Schiffrin, Ernesto L ^c  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b Departments of Medicine

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Bosentan; Deoxycorticosterone salt spontaneously hypertensive rats; DOCA; Endothelin receptors; Endothelium; Fibrinoid necrosis; High blood pressure; Kidney; Resistance arteries

Indexed keywords

BOSENTAN; DEOXYCORTICOSTERONE ACETATE; ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; SODIUM CHLORIDE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART WEIGHT; INTIMA; KIDNEY HYPERTROPHY; KIDNEY NECROSIS; MALIGNANT HYPERTENSION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SUBCUTANEOUS DRUG ADMINISTRATION; SYSTOLIC BLOOD PRESSURE;

EID: 0342468267     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-7061(96)00100-8     Document Type: Article

References (37)

1. Yanagisawa M, Kurihara H, Kimura S, et al: A nove! potent vasoconstrictor peptide produced by vascular endothelial ceils. Nature 1988;332:411-415.
2. Inoue A, Yanagisawa M, Kimura S, et al: The human endotheiin family-3 structurally arid pharmacologically distinct isopeptidcs predicted by 3 separate genes Proc Natl Acad Sei USA 19S9;86:2863-2867.
3. Bobik A, Grooms A, Millar JA, et al: Growth factor activitv of endotheiin on vascular smooth muscle. Am J Physiol 1990;258;C408-C415.
4. Suzuki N, Miyauchi T, Tomobe Y, et al: Plasma concentrations of endolhelin-1 in spontaneously hypertensive rats and DOCA-salt hypertensive rats. Biochem Biophys Res Commun 1990; 167:941-947.
5. Kohno M, Yasumari K, Murakawa K, et al: Plasma imrnunoreactive endotheiin in essential hypertension. Am J Med 1990;88:614-618.
6. Davenport AP, Ashby M), Easton P, et al: A sensitive radioirmrmnoassay measuring endothelin-like immunoreactivity in human plasma: comparison of levels in patients with essential hypertension and normotensive control subjects. Clin Sei 1990;78:261-264.
7. Schiffrin EL, Thibault G: Plasma endotheiin in human essential hypertension. Am J Hypertens 1991:4:303-308.
8. Clozel M: Endotheiin sensitivity and receptor binding in the aorta of spontaneously hypertensive rats. J Hypertens 1989;7:913~917.
9. Nguyen PV, Yang XP, Li G, et al: Contractile responses and signal transduction of er,dothelin-l in aorta and mesenteric vasculature of adult spontaneously hypertensive rats. Can J Physiol Pharmacol 1993;71:473-483.
10. Nguyen PV, Parent A, Deng LY, et al: Endotheiin vascular receptors and responses in DOCA-salt hypertensive rats. Hypertension 1992;i9(suppl 10:11-98-11-104.
11. Deng LY, Schiffrin EL: Effects of endothelin-1 and vasopressin on resistance arteries of spontaneously hypertensive rats. Am J Hypertens 1992;5:817-822.
12. Dohi Y, Luscher TF-. EndotheUrx in hypertensive resistance arteries: intraluminal and exttaluminal dysfunction. Hypertension 1991; 18:543-549.
13. Deng L Y, Schiffrin EL: Effects of endotlielin on resistance arteries of DOCA-salt hypertensive rats. Am J Physio) 1992;262:H1782-H17S7.
14. Schiffrin EL, Deng LY, Larochelle P: Biunlcd effects of endoiheiiri on srnail subcutaneous resistance arteries of mild essential hypertensive patients, J Hypertens 1992; 10:437-44-1.
15. Lariviere R, Thibault G, Schiffrin EL: Increased endotiv L'Hn-1 content in blood vessels of deoxycorticosterorte acetate-salt hypertensive but not in spontaneously hypertensive rats. Hypertension 1993:21:294-300.
16. Wagner OF, Christ G, Wojta I, et al: Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem 1992;267:16066-16068.
17. Lariviere R, Day R, Schiflrin EL: Increased expression of endothelin-1 gene in blood vessels of deoxycorticosterone acetate-salt hypertensive rats. Hypertension 1993;21:916-920.
18. Day R, Larivière R, Schiffrin EL: In situ hybridization shows increased endothelin-1 mRJSJA levels in endorheliai cells of biood vessels of deoxycorticosterone acetale-sall hypertensive rats. Am J Hypertens 1995;8:294-300.
19. Schiffrin EL, Larivière R, Li J-S, et al: Deoxycorticosterone acetate plus salt induce overexpression of vascular endothelir.-l and severe vascular hypertrophy in spontaneously hypertensive rats. Hypertension 1995; 25(part2):769-773.
20. Li J-S, Lariviere R, Schiffrin EL: Effect of a nonselective endothelin antagonist on vascular remodeling in DOCA-salt hypertensive rats. Hypertension 1994;24: 183-188.
21. Li J-S, Schiffrin EL: Effect of chronic treatment of aduit spontaneously hypertensive rats with an endothelin receptor antagonist. Hypertension 1995;25(part 1):495-500.
22. Li J-S, Schiffrin EL: Chronic endothelin receptor antagonist treatment of young spontaneously hypertensive rats. J Hypertens 1995;13:647-657,
23. B endothelin receptor antagonist in DOCA-salt spontaneously hypertensive rats. Br j Pharrnacoi 1995;115:1377-138).
24. Ormsbee HS, Ryan CF: Production of hypertension with deoxycorticosterone acetate-impregnated silicone rubber implants. J Pharmacol Sei 1973;62:255-257.
25. Clozel M, Breu V, Gray GA, et al: Pharmacological characterization of bosentan, a new potent orally active non-peptide endothelin receptor antagonist. J Pharmacol Exp Ther 1994;270:228-235.
26. Raij L, Azar S, Keane WF: Role of hypertension in progressive glomerular immune injury. Hypertension 1985;7:398-404.
27. Okada M, Fukuroda T, Shimamoto K, et al: Antihypertensive effects of BQ-123, a selective endothelin ETA receptor antagonist, in spontaneously hypertensive rats treated with DCCA-salt. Eur J Fhtmnacol 1994;259: 339-34?.
28. Schiff CL, Larivière R, Li J-S, Swntek P: Enhanced expression of endotlielin-1 gene in blood vessels of DOCA-salt hypertensive rats: correlation with vascular structure. J Vase Res 1996;33:235-248.
29. Larivière K, Deny LY, Day R, et al: Increased endothelin-1 gene expressiosi in the endotheiium of coronary arteries and in the endocardium of DOCA-salt hypertensive rats. J Mol Cell Cardiol 1995;27:2123-2131.
30. Deng LY, Day R, Schiffrin EL: Glomenuar and vascular overexpression of endothelin-1 in the kidney of deoxycorticosterone acetate-salt hypertensive rats demonstrated by in sita hybridization histochemisiry. J Am Soc Nephrol (in press).
31. Stacy LD, Scott JW, Granger JP: Control of renal function during intrareual infusion of endothelin. Am j Physio! (Renal Fluid Elcctrol Physiol) 1990;258:F1232-F1236.
32. Wilkins FC, Jr., Alberola A, Mizelle HL, et al: Systemic hemodynarnics and renal function during long-term pathophysiological increases in circulating endothelin. Am J Physiol (Regul Integr Comp Physio!) 1995;6S: R375-R381.
33. Gellai M, Jugus M, Fleicher T, et al: Reversal al posaisehoinic acute rersaJ failure with a selective enaothelin A receptor antagonist in the rat. j Clin Invest 1994, 93:900-906.
34. Chan L, Chittinandana A, Shapiro JI, el ai: Effect of an endothelin receptor antagonist on ischenuc acute renal failure. Am ] Physiol (Renal Fluid Electrol Physiol) 1994;266:F135-F138.
35. St-soko S, Pegram BI., Willis GW,. Frohlich ED: DOCA-salt-induced iTialignant hypertesision m sponiaueuusly hypertensive rats. J Hypertens 1984;2:49-54.
36. Löffler B-M, Breu V, Clozel M: Effect cf different eiidothdin receptor antagonists and of the novel nonpeptide antagonist Ro 46-2005 on endothelin levels in rat plasma. FE3S Leii 1993;333:108-110.
37. B endothelin receptor antagonist boser.tan. Can S Physiol Pharmacol 1.995; 73:390-398.